BMRN
Biomarin Pharmaceutical Inc. - Registered Shares

5,269
Mkt Cap
$10.74B
Volume
1.2M
52W High
$73.51
52W Low
$50.76
PE Ratio
20.96
BMRN Fundamentals
Price
$55.93
Prev Close
$55.52
Open
$55.77
50D MA
$53.78
Beta
0.71
Avg. Volume
2.72M
EPS (Annual)
$2.21
P/B
1.77
Rev/Employee
$933,949.67
Loading...
Loading...
News
all
press releases
Thornburg Investment Management Inc. Sells 7,417 Shares of BioMarin Pharmaceutical Inc. $BMRN
Thornburg Investment Management Inc. trimmed its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 8.7% in the second quarter, according to its most recent disclosure...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Prudential Financial Inc. Boosts Stock Holdings in BioMarin Pharmaceutical Inc. $BMRN
Prudential Financial Inc. boosted its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 115.1% in the second quarter, according to its most recent disclosure with the Securities...
MarketBeat·1d ago
News Placeholder
BioMarin Pharmaceutical Inc. $BMRN Shares Bought by Rhumbline Advisers
Rhumbline Advisers lifted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 1.5% during the second quarter, according to its most recent 13F filing with the...
MarketBeat·1d ago
News Placeholder
Why Is Alkermes (ALKS) Down 5.5% Since Last Earnings Report?
Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·2d ago
News Placeholder
Legal & General Group Plc Increases Stake in BioMarin Pharmaceutical Inc. $BMRN
Legal & General Group Plc increased its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 14.6% during the second quarter, according to its most recent Form 13F filing...
MarketBeat·2d ago
News Placeholder
Handelsbanken Fonder AB Sells 7,700 Shares of BioMarin Pharmaceutical Inc. $BMRN
Handelsbanken Fonder AB cut its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 13.4% in the second quarter, according to the company in its most recent filing with the...
MarketBeat·2d ago
News Placeholder
Intech Investment Management LLC Has $869,000 Position in BioMarin Pharmaceutical Inc. $BMRN
Intech Investment Management LLC cut its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 50.8% during the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·2d ago
News Placeholder
Edmond DE Rothschild Holding S.A. Buys 85,890 Shares of BioMarin Pharmaceutical Inc. $BMRN
Edmond DE Rothschild Holding S.A. lifted its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 15.2% in the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·4d ago
News Placeholder
Mediolanum International Funds Ltd Buys 70,597 Shares of BioMarin Pharmaceutical Inc. $BMRN
Mediolanum International Funds Ltd grew its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 402.4% in the second quarter, according to its most recent disclosure with...
MarketBeat·5d ago
News Placeholder
Neo Ivy Capital Management Sells 19,834 Shares of BioMarin Pharmaceutical Inc. $BMRN
Neo Ivy Capital Management decreased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 79.1% in the 2nd quarter, according to the company in its most recent 13F...
MarketBeat·5d ago

Latest BMRN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.